Today: 29 April 2026
Browse Category

XETRA:MRK 27 June 2025 - 9 January 2026

Why Immunome stock is up today: IMNM jumps 7% as biotech firms up and JPM conference looms

Why Immunome stock is up today: IMNM jumps 7% as biotech firms up and JPM conference looms

Immunome shares rose 7.4% to $21.97 Friday after recent Phase 3 data showed its lead drug varegacestat cut disease progression or death by 84% in desmoid tumor patients. The company plans to file for FDA approval in Q2 2026. Immunome also granted stock options to three new hires and will present at the J.P. Morgan Healthcare Conference on Jan. 14.
9 January 2026
···
$100 B Bank Fraud Scandal Triggers Global Market Rout – DAX Sinks Below 24,000 Amid ‘Cockroach’ Fears

German Stock Market Today, 13 Nov 2025: DAX Closes 1.39% Lower at 24,041 as Siemens Slumps; Merck Rises, Allianz Lifts Guidance

Germany’s DAX fell 1.39% to 24,041.62 on Thursday, its steepest drop since October 2025, after Siemens shares plunged 9.4% on weaker-than-expected earnings and plans to spin off most of its Healthineers stake. The broader STOXX 600 closed down 0.6%. Merck KGaA and Renk rose, while Deutsche Telekom and BASF posted corporate updates. Investors shifted focus to upcoming U.S. economic data.
13 November 2025
·····
Biotech Breakthroughs, Pharma Shakeups & Health Alerts – Global News Roundup (Aug 19–20, 2025)

Biotech Breakthroughs, Pharma Shakeups & Health Alerts – Global News Roundup (Aug 19–20, 2025)

CSL will cut up to 15% of its workforce and spin off its vaccine unit, targeting $500–550 million in annual savings. Medtronic agreed to add two board members and form new committees after Elliott Investment Management took a major stake. Merck KGaA and Skyhawk Therapeutics announced a neurological drug pact worth up to $2 billion. Pfizer, Bristol Myers Squibb, and Regeneron reported improved Q2 2025 earnings.
20 August 2025
·····
Top Biotechnology and Health Tech Trends in 2025: Mid-Year Update and Forecast (Updated: June 27th, 2025)

Top Biotechnology and Health Tech Trends in 2025: Mid-Year Update and Forecast (Updated: June 27th, 2025)

The FDA approved Abeona’s Zevaskyn, the first cell-based gene therapy for RDEB, in April 2025, with launch set for Q3 at $3.1 million. Vertex’s CRISPR therapy Casgevy generated $2 million in Q3 2024. Novo Holdings acquired Catalent for $16.5 billion in January 2025 to secure GLP-1 drug manufacturing. Johnson & Johnson bought Intra-Cellular Therapies for $14.6 billion, expanding its neuroscience portfolio.
27 June 2025
···········

Stock Market Today

  • Soybeans Close Mixed on Tuesday as Planting Progress Accelerates
    April 29, 2026, 1:00 AM EDT. Soybeans finished Tuesday with front-month futures down 1 to 4¼ cents, while deferred contracts edged slightly higher. The national average cash soybean price dipped to $11.15 per bushel. Soymeal futures declined by 40 to 150 cents, and soy oil futures rose by 50 to 112 points. Crush margins, a key profitability measure in soybean processing, hit an all-time high of 3.68 using the Chicago Board of Trade formula. The U.S. Department of Agriculture reported 23% of the U.S. soybean crop planted by April 26, surpassing the 12% average pace. Key states like Illinois and Indiana showed notably faster planting progress. Brazilian soybean export estimates for April were lowered slightly to 15.87 million metric tons. Market watchers will track planting advances amid mixed weather forecasts.

Latest article

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 29.04.2026

29 April 2026
LIVEMarkets rolling coverageStarted: April 29, 2026, 12:00 AM EDTUpdated: April 29, 2026, 1:13 AM EDT Asian Stocks Rise, Oil Prices Slide as UAE Exits OPEC April 29, 2026, 1:13 AM EDT. Asian stocks mostly advanced led by Hong Kong's Hang Seng gaining 1.4%, while oil prices declined following the United Arab Emirates' announcement to leave the Organization of the Petroleum Exporting Countries (OPEC). The UAE, a major oil producer and third largest within OPEC, cited frustration over production quotas limiting its output. Brent crude oil fell 0.5% to $110.71 a barrel, and U.S. crude declined 0.6% to $99.32. The exit
AST SpaceMobile Stock’s May 11 Moment: FCC Win Meets BlueBird 7 Reality

AST SpaceMobile Stock’s May 11 Moment: FCC Win Meets BlueBird 7 Reality

29 April 2026
AST SpaceMobile will hold its first-quarter update call on May 11 after winning FCC approval to deploy a 248-satellite constellation for direct-to-device service. Shares fell 6.8% Tuesday, following the loss of its BlueBird 7 satellite in a failed launch. The company expects insurance to cover the loss and is targeting 45 satellites in orbit by end-2026. Investors are watching launch progress and commercial service timing.
Go toTop